SEC Comment Letter 0000000000-24-008460 to CHINA LIFE INSURANCE CO LTD (CILJF) (CIK 0001268896) (CILJF)
CHINA LIFE INSURANCE CO LTD (CILJF) (CIK 0001268896)
Date: July 25, 2024 · CIK: 0001268896 · Accession: 0000000000-24-008460
AI Filing Summary & Sentiment
File numbers found in text: 001-31914
Letter
July 25, 2024 Li Mingguang President and Executive Director China Life Insurance Company Limited 16 Financial Street Xicheng District Beijing 100033, China Re:China Life Insurance Company Limited Form 20-F for the Fiscal Year Ended December 31, 2022 File No. 001-31914 Dear Li Mingguang: We have completed our review of your filing and have determined not to issue additional comments. Our decision not to issue additional comments regarding your prior responses and the disclosure in your Form 20-F should not be interpreted to mean that we either agree or disagree with your responses or your disclosure regarding the presence of CCP officials on your Board of Directors or the Boards of Directors of your consolidated foreign operating entities, including any conclusions you have made and positions you have taken with respect to such disclosure. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Disclosure Review Program cc:Nicholas Pellicani
Show Raw Text
July 25, 2024
Li Mingguang
President and Executive Director
China Life Insurance Company Limited
16 Financial Street
Xicheng District
Beijing 100033, China
Re:China Life Insurance Company Limited
Form 20-F for the Fiscal Year Ended December 31, 2022
File No. 001-31914
Dear Li Mingguang:
We have completed our review of your filing and have determined not to issue additional
comments. Our decision not to issue additional comments regarding your prior responses and the
disclosure in your Form 20-F should not be interpreted to mean that we either agree or disagree
with your responses or your disclosure regarding the presence of CCP officials on your Board of
Directors or the Boards of Directors of your consolidated foreign operating entities, including any
conclusions you have made and positions you have taken with respect to such disclosure. We
remind you that the company and its management are responsible for the accuracy and adequacy
of their disclosures, notwithstanding any review, comments, action or absence of action by the
staff.
Sincerely,
Division of Corporation Finance
Disclosure Review Program
cc:Nicholas Pellicani